Nidhi Sinha* and Raj Kenia

Vitreo-Retina, Ophthalmology, JPM Rotary Eye Hospital, India

*Corresponding Author: Nidhi Sinha, Vitreo-Retina, Ophthalmology, JPM Rotary Eye Hospital, India.

Received: February 03, 2025; Published: February 08, 2025

Abstract

Diabetic retinopathy (DR) is a leading cause of vision loss, yet screening efforts continue to fall short due to delayed referrals, poor patient adherence, and limited access to ophthalmic care, particularly in rural settings. Despite advancements such as AI-based screening, a critical gap remains in the collaboration between general physicians, endocrinologists, and ophthalmologists. This article highlights the current screening strategies, classification, and management of DR while advocating for a more inclusive approach—training MBBS students in basic fundus examination and leveraging AI to expand screening efforts. Strengthening interdisciplinary coordination and early detection initiatives can significantly improve patient outcomes and reduce the burden of vision loss from DR.

Keywords: Diabetic Retinopathy (DR); Optical Coherence Tomography (OCT); International Council of Ophthalmology (ICO)

References

1. Cheung N., et al. “Diabetic retinopathy”. Lancet 9735 (2010): 124-136.
2. Yau JW., et al. “Global prevalence and major risk factors of diabetic retinopathy”. Diabetes Care3 (2012): 556-564.
3. Aiello LP., et al. “Systemic considerations in the management of diabetic retinopathy”. American Journal of Ophthalmology 2 (2001): 760-776.
4. Wong TY., et al. “Guidelines on diabetic eye care: the International Council of Ophthalmology Recommendations”. Ophthalmology10 (2018): 1608-1622.
5. Wilkinson CP., et al. “Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales”. Ophthalmology 9 (2003): 1677-1682.
6. Mitchell P and Wong TY. “Management paradigms for diabetic macular edema”. American Journal of Ophthalmology1 (2014): 5-6.
7. Schmidt-Erfurth U., et al. “Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA)”. Ophthalmologica4 (2017): 185-222.
8. Virgili G., et al. “Anti-VEGF for diabetic macular edema: a network meta-analysis”. Cochrane Database of Systematic Reviews 6 (2017): CD007419.
9. Brown DM., et al. “Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies”. Ophthalmology10 (2015): 2044-2052.

Citation

Citation: Nidhi Sinha and Raj Kenia. “Screening for Diabetic Retinopathy – A Long Way to Go".Acta Scientific Ophthalmology 8.2 (2025): 05-06.

Copyright

Copyright: © 2025 Nidhi Sinha and Raj Kenia. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.